Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Gastrointestinal Therapeutics and Diagnostics - Technologies and Global Markets - Expected to Reach $63.8 Billion in 2021 - Research and Markets

Research and Markets
Posted on: 06 Oct 16

Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

Scope of the Report:

  • An overview of the global markets for gastrointestinal therapeutics and diagnostics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
  • Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.

Companies Mentioned:

  • Allergan Plc
  • Ardelyx Inc.
  • Astellas Pharma Inc.
  • AstraZeneca
  • Celgene Corp.
  • Clovis Oncology
  • Daewoong Pharmaceutical Co. Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Horizon Pharma Plc
  • ImmunogenX
  • Immunomedics
  • Merck & Co.
  • Merrimack Pharmaceuticals Inc.
  • New Link Genetics
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Roche
  • Sanofi
  • Shire
  • Sucampo Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • Synthetic Biologics
  • Taiho Pharmaceutical Co. Ltd.
  • Takeda Pharmaceuticals
  • Valeant Pharmaceuticals

Key Topics Covered:

1: Introduction - Complimentary

2: Executive Summary

3: Overview

4: Etiology

5: Prescription Therapy Market

6: OTC Therapy Market

7: Diagnostics And Devices Market

8: Gastrointestinal Product Pipeline

9: Patents

10: Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/l5lhfx/gastrointestinal.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161006006265/en/

Business Wire
www.businesswire.com

Last updated on: 06/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.